<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">25614348</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>12</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1433-0423</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>112</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft</Title>
          <ISOAbbreviation>Ophthalmologe</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Papillary edema in Muckle-Wells syndrome].</ArticleTitle>
        <Pagination>
          <StartPage>778</StartPage>
          <EndPage>782</EndPage>
          <MedlinePgn>778-82</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00347-014-3221-y</ELocationID>
        <Abstract>
          <AbstractText>Papillary edema may occur isolated without functional impairment or secondary related to various syndromes, increased intracerebral pressure or associated with medicinal treatment. The Muckle-Wells syndrome is a rare disease, which among many other symptoms can lead to optic disc swelling and recurrent increase in intracerebral pressure. Besides familial cold-induced autoinflammatory syndrome (FCAS) and neonatal onset multisystem inflammatory disease (NOMID), the Muckle-Wells syndrome also belongs to the cryopyrin-associated periodic syndromes (CAPS). In most cases of CAP syndromes there is an underlying genetic disorder that leads to overproduction of interleukin-1β (IL-1β); therefore, typical symptoms include inflammation reactions, such as repeated skin rash, fatigue, fever, joint pain and conjunctivitis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wirths</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Universitätsaugenklinik Münster, Domagkstr. 15, 48149, Münster, Deutschland. Gabriele.wirths@ukmuenster.de.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grenzebach</LastName>
            <ForeName>U</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Universitätsaugenklinik Münster, Domagkstr. 15, 48149, Münster, Deutschland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eter</LastName>
            <ForeName>N</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Universitätsaugenklinik Münster, Domagkstr. 15, 48149, Münster, Deutschland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>ger</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Papillenschwellung bei Muckle-Wells-Syndrom.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Ophthalmologe</MedlineTA>
        <NlmUniqueID>9206148</NlmUniqueID>
        <ISSNLinking>0941-293X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056587" MajorTopicYN="N">Cryopyrin-Associated Periodic Syndromes</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010211" MajorTopicYN="N">Papilledema</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D041623" MajorTopicYN="N">Tomography, Optical Coherence</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cryopyrin-associated periodic syndromes</Keyword>
        <Keyword MajorTopicYN="N">Genetic disorder</Keyword>
        <Keyword MajorTopicYN="N">Inflammatory reaction</Keyword>
        <Keyword MajorTopicYN="N">Intracerebral pressure</Keyword>
        <Keyword MajorTopicYN="N">Papillary edema</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2015</Year>
          <Month>1</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2015</Year>
          <Month>1</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>12</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">25614348</ArticleId>
        <ArticleId IdType="doi">10.1007/s00347-014-3221-y</ArticleId>
        <ArticleId IdType="pii">10.1007/s00347-014-3221-y</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>J Ophthalmic Inflamm Infect. 2011 Sep;1(3):133-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21484180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Genet. 2001 Nov;29(3):301-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11687797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arch Ophthalmol. 2000 Oct;118(10):1386-92</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11030821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arthritis Rheum. 2004 Feb;50(2):607-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14872505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Rheum Dis. 2015 Nov;74(11):2043-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25038238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Rheumatol. 2014 Aug;41(8):1721-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25086140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Z Rheumatol. 2012 Apr;71(3):199-208</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22527214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rheumatology (Oxford). 2014 Jun;53(6):1095-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24501247</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
